DK130296B - Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte. - Google Patents

Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte.

Info

Publication number
DK130296B
DK130296B DK165269AA DK165269A DK130296B DK 130296 B DK130296 B DK 130296B DK 165269A A DK165269A A DK 165269AA DK 165269 A DK165269 A DK 165269A DK 130296 B DK130296 B DK 130296B
Authority
DK
Denmark
Prior art keywords
sydnonimine
halo
salts
amino
substituted
Prior art date
Application number
DK165269AA
Other languages
Danish (da)
English (en)
Other versions
DK130296C (pt
Inventor
M Gotz
K Freter
K Zeile
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK130296B publication Critical patent/DK130296B/da
Application granted granted Critical
Publication of DK130296C publication Critical patent/DK130296C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK165269AA 1968-03-26 1969-03-25 Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte. DK130296B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (2)

Publication Number Publication Date
DK130296B true DK130296B (da) 1975-02-03
DK130296C DK130296C (pt) 1975-06-30

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165269AA DK130296B (da) 1968-03-26 1969-03-25 Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte.

Country Status (18)

Country Link
AT (1) AT285619B (pt)
BE (1) BE730510A (pt)
BG (1) BG15220A3 (pt)
BR (1) BR6907417D0 (pt)
CA (1) CA945990A (pt)
CH (1) CH519511A (pt)
DE (1) DE1770061A1 (pt)
DK (1) DK130296B (pt)
ES (2) ES364979A1 (pt)
FI (1) FI54480C (pt)
FR (1) FR2004770A1 (pt)
GB (1) GB1219254A (pt)
HU (1) HU162735B (pt)
IE (1) IE32708B1 (pt)
IL (1) IL31909A (pt)
NL (1) NL6904632A (pt)
SE (1) SE374746B (pt)
YU (1) YU69369A (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) * 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
HU162735B (pt) 1973-04-28
NL6904632A (pt) 1969-09-30
AT285619B (de) 1970-11-10
ES364979A1 (es) 1971-02-16
IE32708L (en) 1969-09-26
ES376981A1 (es) 1972-05-01
BG15220A3 (bg) 1975-11-21
IL31909A0 (en) 1969-05-28
FI54480B (fi) 1978-08-31
IE32708B1 (en) 1973-10-31
BE730510A (pt) 1969-09-26
FR2004770A1 (pt) 1969-11-28
GB1219254A (en) 1971-01-13
CH519511A (de) 1972-02-29
YU69369A (en) 1978-09-18
BR6907417D0 (pt) 1973-04-12
IL31909A (en) 1973-01-30
FI54480C (fi) 1978-12-11
DE1770061A1 (de) 1971-09-16
SE374746B (pt) 1975-03-17
DK130296C (pt) 1975-06-30
CA945990A (en) 1974-04-23

Similar Documents

Publication Publication Date Title
DK126193B (da) Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin.
DK122964B (da) Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater.
DK122965B (da) Analogifremgangsmåde til fremstilling af derivater af thiazolylbenzoesyre.
DK124473B (da) Fremgangsmåde til fremstilling af cyclopropanderivater.
DK133465B (da) Analogifremgangsmåde til fremstilling af pyridoxin-alfa-ketoglutarat.
DK131628B (da) Fremgangsmåde til fremstilling af tioninderivater.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK125251B (da) Analogifremgangsmåde til fremstilling af thiazolylmalonsyrederivater.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK123471B (da) Analogifremgangsmåde til fremstilling af benzyliden-amino-oxyalkylcarboxylsyrederivater.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK128540B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinonforbindelser.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK119304B (da) Fremgangsmåde til fremstilling af D-ribose.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK130210B (da) Fremgangsmåde til fremstilling af sulfoniumsalte.
DK120292B (da) Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater.
DK129282B (da) Fremgangsmåde til fremstilling af indanderivater.
DK135287B (da) Analogifremgangsmåde til fremstilling af styrylthiazoliumsalte.
DK140726B (da) Fremgangsmåde til fremstilling af delta2-cephalosporin-forbindelser.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK140284B (da) Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner.
DK131291B (da) Fremgangsmåde til fremstilling af hexaorganoditinforbindelser.
DK130296B (da) Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte.